TTNPW:Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) - Stock Price Quote and Dividend Data
TTNPW STOCK PRICE LATEST CLOSE
< $0.01
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) Stock Price Information
52-Week Low/High Stock Price$0.00 - $0.01
Percent Held by Institutions0.00%
Revenue$4,000
Net Income$-7,554,000
Cash Flow$-8,830,000
EPS-2.29%
Market Cap$0
PE Ratio to Industry86%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months-89.47%
Total Return Last 3 Years-99.44%
Total Return Last 5 Years0.00%
Latest Trade DateOct. 09, 2024
Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) Annual Stock Dividends
No Data available for Payment History.
Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) Dividend Payment History
| No dividends retrieved for TTNPW |
Wt Cl B Exp 10/18/2024/Titan Pharmaceuticals Inc (DE) Other Dividend Details
Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
May. 03, 2024TTNPW STOCK PRICE DECREASE: Titan Pharmaceuticals Inc (DE) on 05-03-2024 decreased stock price > 10% from $0.01 to $0.00
Apr. 06, 2024TTNPW STOCK PRICE INCREASE: Titan Pharmaceuticals Inc (DE) on 04-06-2024 increased stock price > 10% from $0.00 to $0.01
Dec. 23, 2023TTNPW STOCK PRICE DECREASE: Titan Pharmaceuticals Inc (DE) on 12-23-2023 decreased stock price > 10% from $0.01 to $0.00
Oct. 19, 2023TTNPW STOCK PRICE INCREASE: Titan Pharmaceuticals Inc (DE) on 10-19-2023 increased stock price > 10% from $0.00 to $0.01
Jun. 29, 2023TTNPW STOCK PRICE DECREASE: Titan Pharmaceuticals Inc (DE) on 06-29-2023 decreased stock price > 10% from $0.01 to $0.00
Jun. 14, 2023TTNPW STOCK PRICE INCREASE: Titan Pharmaceuticals Inc (DE) on 06-14-2023 increased stock price > 10% from $0.00 to $0.01
May. 09, 2023TTNPW STOCK PRICE DECREASE: Titan Pharmaceuticals Inc (DE) on 05-09-2023 decreased stock price > 10% from $0.01 to $0.00
May. 05, 2023TTNPW STOCK PRICE INCREASE: Titan Pharmaceuticals Inc (DE) on 05-05-2023 increased stock price > 10% from $0.00 to $0.01
Apr. 27, 2023TTNPW STOCK PRICE DECREASE: Titan Pharmaceuticals Inc (DE) on 04-27-2023 decreased stock price > 10% from $0.01 to $0.00
Apr. 27, 2023TTNPW STOCK PRICE 52 WEEK LOW: Titan Pharmaceuticals Inc (DE) on 04-27-2023 hit a 52 week low of $0.00
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
